UBS Group Initiates Coverage on Welltower (NYSE:WELL)

Key Points

• UBS Group has initiated coverage on Welltower (NYSE:WELL) with a "buy" rating and a price target of $195.00, indicating a potential upside of 17.11% from the current stock price.
• Other analysts have expressed positive outlooks, with one rating as Strong Buy, eight as Buy, and overall a consensus of "Moderate Buy" with an average target price of $177.55.
• Welltower reported earnings of $1.28 per share for the last quarter, exceeding expectations, with quarterly revenue increasing by 39.6% compared to the same quarter last year.

Equities research analysts at UBS Group started coverage on shares of Welltower (NYSE:WELL - Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set a "buy" rating and a $195.00 price target on the real estate investment trust's stock. UBS Group's price objective suggests a potential upside of 17.80% from the company's previous close.

Other research analysts have also issued reports about the stock. Evercore ISI boosted their price target on shares of Welltower from $175.00 to $183.00 and gave the stock an "in-line" rating in a research note on Monday, September 15th. Wells Fargo & Company boosted their price target on shares of Welltower from $175.00 to $185.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 27th. Scotiabank boosted their price target on shares of Welltower from $172.00 to $181.00 and gave the stock an "outperform" rating in a research note on Thursday, August 28th. Finally, Raymond James Financial reiterated a "strong-buy" rating on shares of Welltower in a research note on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Welltower has an average rating of "Moderate Buy" and a consensus price target of $177.55.

Welltower Stock Performance

NYSE WELL traded down $1.00 during trading on Friday, reaching $165.53. The company's stock had a trading volume of 20,205,185 shares, compared to its average volume of 2,294,890. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.19 and a current ratio of 4.19. The firm has a market cap of $110.71 billion, a price-to-earnings ratio of 93.52, a P/E/G ratio of 1.86 and a beta of 0.93. Welltower has a twelve month low of $122.34 and a twelve month high of $171.09. The business's fifty day moving average price is $165.11 and its 200-day moving average price is $154.88.

Welltower (NYSE:WELL - Get Free Report) last posted its quarterly earnings data on Monday, July 28th. The real estate investment trust reported $1.28 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.06. Welltower had a net margin of 12.18% and a return on equity of 3.38%. The company had revenue of $2.55 billion for the quarter, compared to analyst estimates of $2.49 billion. During the same period in the previous year, the business posted $1.05 earnings per share. Welltower's quarterly revenue was up 39.6% on a year-over-year basis. Welltower has set its FY 2025 guidance at 5.060-5.14 EPS. As a group, analysts anticipate that Welltower will post 4.88 EPS for the current fiscal year.

Insider Activity

In other news, Director Andrew Gundlach acquired 20,000 shares of Welltower stock in a transaction that occurred on Monday, June 30th. The shares were acquired at an average price of $151.46 per share, with a total value of $3,029,200.00. Following the completion of the purchase, the director owned 20,000 shares of the company's stock, valued at approximately $3,029,200. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.21% of the company's stock.

Hedge Funds Weigh In On Welltower

Institutional investors and hedge funds have recently modified their holdings of the company. Zions Bancorporation National Association UT grew its holdings in shares of Welltower by 4.2% in the 2nd quarter. Zions Bancorporation National Association UT now owns 1,604 shares of the real estate investment trust's stock worth $247,000 after purchasing an additional 65 shares during the last quarter. Cornerstone Wealth Group LLC grew its holdings in Welltower by 4.7% during the 2nd quarter. Cornerstone Wealth Group LLC now owns 1,460 shares of the real estate investment trust's stock worth $225,000 after acquiring an additional 66 shares during the last quarter. Good Life Advisors LLC grew its holdings in Welltower by 1.2% during the 1st quarter. Good Life Advisors LLC now owns 5,744 shares of the real estate investment trust's stock worth $880,000 after acquiring an additional 69 shares during the last quarter. Rise Advisors LLC grew its holdings in Welltower by 23.3% during the 1st quarter. Rise Advisors LLC now owns 365 shares of the real estate investment trust's stock worth $56,000 after acquiring an additional 69 shares during the last quarter. Finally, Bridgewater Advisors Inc. grew its holdings in Welltower by 5.1% during the 2nd quarter. Bridgewater Advisors Inc. now owns 1,461 shares of the real estate investment trust's stock worth $242,000 after acquiring an additional 71 shares during the last quarter. Hedge funds and other institutional investors own 94.80% of the company's stock.

Welltower Company Profile

Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.